These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The combined action of azlocillin and sisomicin in a model simulating the in vivo serum kinetics. Haller I Infection; 1983; 11 Suppl 2():S81-2. PubMed ID: 6423547 [TBL] [Abstract][Full Text] [Related]
9. Comparative clinical evaluation of azlocillin and gentamicin. Sabbaj J; Torres M; Loza L J Antimicrob Chemother; 1983 May; 11 Suppl B():175-81. PubMed ID: 6619027 [TBL] [Abstract][Full Text] [Related]
10. A comparison of azlocillin and gentamicin in the treatment of serious infections caused by Pseudomonas aeruginosa. Gonzalez MA J Antimicrob Chemother; 1983 May; 11 Suppl B():169-74. PubMed ID: 6352600 [TBL] [Abstract][Full Text] [Related]
11. Prolonged bleeding time during azlocillin therapy. Dijkmans BA; Van Der Meer JW; Boekhout-Mussert MJ; Zaal-De Jong M; Mattie H J Antimicrob Chemother; 1980 Jul; 6(4):554-6. PubMed ID: 7430018 [No Abstract] [Full Text] [Related]
12. [Perichondritis of the auricula. Prevention of defective healing with azlocillin]. Ganz H HNO; 1982 Nov; 30(11):428-9. PubMed ID: 7161155 [No Abstract] [Full Text] [Related]
14. The use of azlocillin to treat serious infections. Neu HC; Francke EL; Ortiz-Neu C; Prince AS J Antimicrob Chemother; 1983 May; 11 Suppl B():141-7. PubMed ID: 6619023 [TBL] [Abstract][Full Text] [Related]
15. In vitro assessment of combined antibiotic and mucolytic treatment for Pseudomonas aeruginosa infection in cystic fibrosis. Heaf DP; Webb GJ; Matthew DJ Arch Dis Child; 1983 Oct; 58(10):824-6. PubMed ID: 6416185 [TBL] [Abstract][Full Text] [Related]
16. Azlocillin in the treatment of serious infection with Pseudomonas aeruginosa. Eykyn SJ J Antimicrob Chemother; 1982 May; 9(5):395-403. PubMed ID: 6807951 [No Abstract] [Full Text] [Related]
17. Pharmacokinetics and clinical aspects of azlocillin in paediatrics. Heimann G J Antimicrob Chemother; 1983 May; 11 Suppl B():127-35. PubMed ID: 6619022 [TBL] [Abstract][Full Text] [Related]
18. Azlocillin pharmacokinetics in patients with cystic fibrosis. Bosso JA; Saxon BA; Herbst JJ; Matsen JM Antimicrob Agents Chemother; 1984 May; 25(5):630-2. PubMed ID: 6732230 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of azlocillin in vitro and in discriminative animal models of infection. Scheld WM; Brodeur JP; Keeley JM; Field MR; Kelly WJ; Long WJ; Zak O J Antimicrob Chemother; 1983 May; 11 Suppl B():51-68. PubMed ID: 6619033 [No Abstract] [Full Text] [Related]
20. Pseudomonas meningitis treated with azlocillin. Ellis CJ; Walter PH Br Med J; 1979 Sep; 2(6193):767. PubMed ID: 519187 [No Abstract] [Full Text] [Related] [Next] [New Search]